InvestorsHub Logo
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

Re: leifsmith post# 189

Wednesday, 11/03/2021 3:10:49 PM

Wednesday, November 03, 2021 3:10:49 PM

Post# of 547
Yes, leifsmith, it isn't easy to untangle. My GUESS is that what we now call ORAVAX was a wholly owned subsidiary of MYMD, perhaps not by that name, but was nothing more than the Premas Biotech trivalent vaccine which Akers had ordered from Premas. Then someone got the brilliant idea that making it available as a pill (Oramed), would enhance its value astronomically. Since the pill version is what provides the astronomic value to the vaccine, Oramed ended up owning 87% of the newly formed ORAVAX , and MYMD 13%.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMD News